Variant report
Variant | nsv965744 |
---|---|
Chromosome Location | chr6:88151722-88154668 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:88152186-88152321 | HepG2 | liver: | n/a | n/a |
2 | CHD2 | chr6:88154082-88154423 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr6:88152154-88152185 | GM12878 | blood: | n/a | n/a |
4 | GTF2F1 | chr6:88154241-88154404 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | JUN | chr6:88154398-88154495 | K562 | blood: | n/a | n/a |
6 | MAX | chr6:88154174-88154407 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | SIN3A | chr6:88154154-88154515 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | SP1 | chr6:88154060-88154449 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | SP1 | chr6:88154071-88154635 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | TCF12 | chr6:88154104-88154425 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | TCF12 | chr6:88154171-88154476 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | TEAD4 | chr6:88154007-88154557 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | TEAD4 | chr6:88154022-88154588 | ECC-1 | luminal epithelium: | n/a | n/a |
14 | TEAD4 | chr6:88154117-88154463 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | TEAD4 | chr6:88154036-88154521 | HepG2 | liver: | n/a | n/a |
16 | TEAD4 | chr6:88153946-88154647 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | YY1 | chr6:88153910-88154431 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | YY1 | chr6:88154001-88154409 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RARS2-2 | chr6:88150883-88151864 | NONHSAT113905 |
2 | lnc-RARS2-1 | chr6:88154113-88154893 | NONHSAT113906 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000218793 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528026117 | chr6:88151726-88151727 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs377334344 | chr6:88151745-88151746 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs376007565 | chr6:88151800-88151801 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs549244862 | chr6:88151801-88151802 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs144416153 | chr6:88151812-88151813 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs531353581 | chr6:88151817-88151818 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs114502715 | chr6:88151866-88151867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs570276587 | chr6:88151890-88151891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192487338 | chr6:88151904-88151905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538727688 | chr6:88151919-88151920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547658471 | chr6:88151972-88151973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114942254 | chr6:88151985-88151986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182476451 | chr6:88152000-88152001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545407116 | chr6:88152037-88152038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576226170 | chr6:88152110-88152111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538238007 | chr6:88152215-88152216 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs148606366 | chr6:88152238-88152239 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs577758221 | chr6:88152282-88152283 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs545097591 | chr6:88152304-88152305 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs565344882 | chr6:88152350-88152351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560343340 | chr6:88152399-88152400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537898236 | chr6:88152425-88152426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187460928 | chr6:88152457-88152458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192944654 | chr6:88152463-88152464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9294379 | chr6:88152535-88152536 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs531869446 | chr6:88152577-88152578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184639978 | chr6:88152641-88152642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs9444499 | chr6:88152642-88152643 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs386703515 | chr6:88152667-88152668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143203411 | chr6:88152673-88152674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs9294381 | chr6:88152681-88152682 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs529934821 | chr6:88152743-88152744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576728765 | chr6:88152767-88152768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569946191 | chr6:88152797-88152798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531038465 | chr6:88152899-88152900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556570217 | chr6:88152949-88152950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189765137 | chr6:88152971-88152972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79349767 | chr6:88153030-88153031 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs538783213 | chr6:88153054-88153055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs553865683 | chr6:88153093-88153094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572179591 | chr6:88153159-88153160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543209439 | chr6:88153171-88153172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs146685387 | chr6:88153199-88153200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192243138 | chr6:88153303-88153304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs199615548 | chr6:88153308-88153309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184307930 | chr6:88153326-88153327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs140300749 | chr6:88153334-88153335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144072385 | chr6:88153380-88153381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs189519245 | chr6:88153478-88153479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs9450685 | chr6:88153608-88153609 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
abnormal development | 18461090 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 19490664 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:88150000-88154400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr6:88153400-88155200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr6:88153800-88154000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr6:88154000-88154200 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
5 | chr6:88154000-88154400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:88154000-88154400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr6:88154000-88154600 | Enhancers | Fetal Heart | heart |
8 | chr6:88154000-88154800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr6:88154000-88154800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
10 | chr6:88154000-88154800 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr6:88154000-88154800 | Enhancers | H9 Cell Line | embryonic stem cell |
12 | chr6:88154000-88154800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr6:88154000-88154800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr6:88154000-88154800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr6:88154000-88154800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr6:88154000-88154800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr6:88154000-88154800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
18 | chr6:88154000-88155200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
19 | chr6:88154000-88155200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr6:88154200-88154400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
21 | chr6:88154400-88154600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr6:88154400-88154600 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
23 | chr6:88154400-88154800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr6:88154400-88154800 | Flanking Active TSS | HUES48 Cell Line | embryonic stem cell |
25 | chr6:88154400-88155200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
26 | chr6:88154600-88154800 | Enhancers | HUES6 Cell Line | embryonic stem cell |